HSP110 expression correlates with c-MYC, BCL6 and MYD88 protein expression in tumor biopsies of DLBCL, and HSP110 siRNA-mediated knockdown leads to decreases in these oncogenes and cells survival [32, 33]. The gene discussed is HSPH1; the disease is diffuse large B-cell lymphoma.